Tag: PRRT

Josh Mailman_5

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging 2014 Meeting

April 25, 2014

Josh Mailman, President of the NorCal CarciNET Community  and Chair of the Patient Advocacy Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day on June…

READ MORE
Jim Weiveris

10 Highlights of the Year 2013 for the Carcinoid and Neuroendocrine Tumor Community

December 18, 2013

As the Carcinoid Cancer Foundation looks back on the year 2013, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…

READ MORE
Netty, Name Your NET Hero

Worldwide NET Cancer Awareness Day, November 10, 2013

November 8, 2013

Name Your NET Hero, a global webinar, a bridge striped in alternating patterns of purple and white lights, walks, conferences, and more are some of the many ways people around the globe are participating in the 4th annual Worldwide NET Cancer Awareness

READ MORE
Richard R.P. Warner, MD

New Jersey Carcinoid Cancer NETwork Conference in November, Registration through October 16

October 2, 2013

Three of the country’s leading carcinoid and neuroendocrine cancer specialists will be featured speakers for the New Jersey Carcinoid Cancer NETwork Conference. to be held on Saturday, November 2, 2013 at the Crowne Plaza in Edison, New Jersey.  Carcinoid/NETs: 

READ MORE
Society of Nuclear Medicine Patient Program June 2013

Neuroendocrine Tumors Featured in Society of Nuclear Medicine and Molecular Imaging Patient Program

May 22, 2013

Josh Mailman, President of the NorCal CarciNET support group and Chair of the Patient Advocate Advisory Board for the Society of Nuclear Medicine and Molecular Imaging (SNMMI), will give the Welcome presentation for the SNMMI Patient Education Day …

READ MORE
Excel Diagnostics logo_2

Excel Diagnostics and Nuclear Oncology Center Selected For New Investigational PRRT Treatment and Gallium Scan for Carcinoid and Neuroendocrine Tumor Patients

May 15, 2013

For carcinoid, pancreatic neuroendocrine tumor, and other NET cancer patients seeking the most advanced nuclear medicine opportunities in  the United States, Excel Diagnostics and Nuclear Oncology Center  in Houston, Texas, in collaboration with…

READ MORE
2nd World Congress Gallium 68

2nd World Congress on Ga-68, Molecular Imaging & Targeted Radionuclide Therapy

January 10, 2013

Chandigarh, India will be the site of the 2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals), Molecular Imaging (PET/CT), Targeted Radionuclide Therapy and Dosimetry:  On the Way to Personalized Medicine from February 28 through…

READ MORE
Ebrahim S. Delpassand, MD, FACNM

FDA Approves Amendment for PRRT Clinical Trial in Texas

August 2, 2012

BREAKING NEWS:  The Food and Drug Administration (FDA) has just approved the RadioIsotope Therapy of America (RITA) Foundation’s amendment to the Investigational New Drug (IND) protocol for intra-hepatic artery administration of Lu-177 Octreotate

READ MORE
Jan Naritomi-Hart

10 Highlights of the Year 2011 for the Carcinoid and Neuroendocrine Tumor Community

December 15, 2011

As the Carcinoid Cancer Foundation looks back on the year 2011, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community.  Here are 10 of the year’s important stories:

1)     The FDA approved the first…

READ MORE
Richard R.P. Warner, MD2

Pancreatic Neuroendocrine Tumors: A Rare Cancer

August 26, 2011

From your next door neighbor to Steve Jobs, co-founder of Apple who just announced that he is stepping down as CEO of the company, pancreatic neuroendocrine tumors (pNETs) affect less than 1 person in 100,000 in the United States.  This rare cancer is often…

READ MORE